CIK 0001055726 · Non-accelerated filer<br>Smaller reporting company
INOVIO PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- INO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330969592
- Phone
- 8584103134
- Business address
- 660 W. GERMANTOWN PIKE, SUITE 110, PLYMOUTH MEETING, PA, 19462
- Former names
- INOVIO BIOMEDICAL CORP, GENETRONICS BIOMEDICAL CORP, GENETRONICS BIOMEDICAL LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-26 | Shea Jacqueline Elizabeth Chief Executive Officer | Option exercise · Restricted Stock Unit | −5,853 | 5,852 | ||
| 2024-02-26 | Humeau Laurent Chief Scientific Officer | Option exercise | +1,878 | 19,764 | ||
| 2024-02-26 | Humeau Laurent Chief Scientific Officer | Shares withheld for taxes | −770 | $8.16 | $6K | 18,994 |
| 2024-02-26 | Humeau Laurent Chief Scientific Officer | Option exercise | +3,856 | 22,850 | ||
| 2024-02-26 | Humeau Laurent Chief Scientific Officer | Shares withheld for taxes | −1,581 | $8.16 | $13K | 21,269 |
| 2024-02-26 | Humeau Laurent Chief Scientific Officer | Option exercise · Restricted Stock Unit | −1,878 | 0 | ||
| 2024-02-26 | Humeau Laurent Chief Scientific Officer | Option exercise · Restricted Stock Unit | −3,856 | 3,855 | ||
| 2024-02-26 | KIES PETER CFO | Option exercise | +1,878 | 21,627 | ||
| 2024-02-26 | KIES PETER CFO | Shares withheld for taxes | −1,108 | $8.16 | $9K | 20,519 |
| 2024-02-26 | KIES PETER CFO | Option exercise | +3,997 | 24,516 | ||
| 2024-02-26 | KIES PETER CFO | Shares withheld for taxes | −2,358 | $8.16 | $19K | 22,158 |
| 2024-02-26 | KIES PETER CFO | Option exercise · Restricted Stock Unit | −1,878 | 0 | ||
| 2024-02-26 | KIES PETER CFO | Option exercise · Restricted Stock Unit | −3,997 | 3,997 | ||
| 2023-06-30 | Sumner Michael John Chief Medical Officer | Option exercise | +35,000 | 35,000 | ||
| 2023-06-30 | Sumner Michael John Chief Medical Officer | Option exercise · Restricted Stock Unit | −35,000 | 70,000 | ||
| 2023-06-05 | Zoth Lota S. Director | Sale | −5,700 | $0.56 | $3K | 52,716 |
| 2023-05-16 | Zoth Lota S. Director | Option exercise | +19,000 | 58,416 | ||
| 2023-05-16 | Zoth Lota S. Director | Option exercise · Restricted Stock Unit | −19,000 | 0 | ||
| 2023-05-16 | YARNO WENDY L Director | Option exercise | +19,000 | 74,153 | ||
| 2023-05-16 | YARNO WENDY L Director | Option exercise · Restricted Stock Unit | −19,000 | 0 |
Page 12 of 17 · 322 trades